Table 1.
Clinical and demographic characteristics
| Variable | |
| Mean age (years) (SD) | 41.1 (14.3) |
| Sex (%) | |
| Female | 25 (59.5) |
| Male | 17 (40.5) |
| Mean duration of uveitis (years) (SD) | 4.7 (3.5) |
| Current treatment (%) | |
| None | 6 (14.3) |
| Topical corticosteroids alone | 9 (21.4) |
| Oral prednisolone alone | 3 (7.1) |
| Oral prednisolone plus immunosuppressant(s)* | 23 (54.8) |
| Immunosuppressant alone | 1 (2.4) |
| Laterality (%) | |
| Unilateral | 12 (28.6) |
| Bilateral | 30 (71.4) |
| Associated systemic disease (%) | |
| None | 33 (78.6) |
| Sarcoidosis | 6 (14.3) |
| Multiple sclerosis | 3 (7.1) |
| Medical co-morbidities (%) | |
| None | 24 (57.1) |
| Hypertension | 7 (16.7) |
| Ischaemic heart disease | 2 (4.8) |
| Asthma | 2 (4.8) |
| Hypothyroidism | 1 (2.4) |
| Diabetes mellitus | 1 (2.4) |
| Rheumatoid arthritis | 1 (2.4) |
*Immunosuppressants included ciclosporin A, tacrolimus, mycophenolate mofetil, azathioprine, and methotrexate.